Method for synthesizing steroid progestogen
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU CHUANGUO PHARMA CO LTD
- Publication Date
- 2006-11-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention belongs to the technical field of medicinal chemistry. In particular it relates to methods for the synthesis of steroidal progestogens. Background technique:
[0002] 13β-Ethyl-11-Methylene-18.19-Dianox-17α-Pregn-4-ene-20-Ethynyl-17β-Hydroxy is a steroidal progestin contraceptive that can inhibit ovulation and gonadotropin Secretion, the trade name is Marvelon. 13β-ethyl-11-methylene-18.19-bisanox-17α-pregnant-4-en-3-ketone-20-ethynyl-17β-hydroxyl is a derivative of desogestrel, and the Netherlands Organon company will It was developed into a single-root subcutaneous sustained-release long-acting contraceptive implant with the trade name Implanon. Its synthetic route has following several kinds:
[0003] (1) Synthesis of 13β-ethyl-11-methylene-18.19-bisanth-17α-pregna-4-ene- from 11-hydroxyestr-5-ene-3,17-dione 20-ethynyl-17β-hydroxyl, see reaction formula 1:
[0004]
[0005]
[0006] Reaction one ...